{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:45:13Z","timestamp":1747165513873,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jns.2014.07.004","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T03:30:58Z","timestamp":1404876658000},"page":"252-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impulse control and repetitive behaviors in Parkinson's disease \u2014 Are there differences in the relation to dopamine agonist treatment?"],"prefix":"10.1016","volume":"345","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2510-831X","authenticated-orcid":false,"given":"Johanne Hatteland","family":"Somme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"G\u00f3mez-Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Tijero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koldo","family":"Berganzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Lezcano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jose","family":"Zarranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jns.2014.07.004_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"issue":"Pt 5","key":"10.1016\/j.jns.2014.07.004_bb0010","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","article-title":"Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study","volume":"132","author":"Steeves","year":"2009","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jns.2014.07.004_bb0015","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/mp.2009.95","article-title":"Insights into pathophysiology of punding reveal possible treatment strategies","volume":"15","author":"Fasano","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"7","key":"10.1016\/j.jns.2014.07.004_bb0020","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.jns.2014.07.004_bb0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.parkreldis.2009.12.002","article-title":"Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease","volume":"16","author":"Lee","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.jns.2014.07.004_bb0030","first-page":"257","article-title":"Rotigotine in the treatment of Parkinson's disease. A study on a sample of 150 patients","volume":"46","author":"Ruiz-Huete","year":"2008","journal-title":"Rev Neurol"},{"issue":"9","key":"10.1016\/j.jns.2014.07.004_bb0035","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00702-013-1001-5","article-title":"The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease","volume":"120","author":"Giladi","year":"2013","journal-title":"J Neural Transm"},{"issue":"2 Suppl. 1","key":"10.1016\/j.jns.2014.07.004_bb0040","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.65.2_suppl_1.S3","article-title":"A novel dopamine agonist for the transdermal treatment of Parkinson's disease","volume":"65","author":"Jenner","year":"2005","journal-title":"Neurology"},{"issue":"2 Suppl. 1","key":"10.1016\/j.jns.2014.07.004_bb0045","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1212\/WNL.65.2_suppl_1.S6","article-title":"A promising new technology for Parkinson's disease","volume":"65","author":"Pfeiffer","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2014.07.004_bb0050","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/mds.21118","article-title":"Punding and dyskinesias","volume":"21","author":"Silveira-Moriyama","year":"2006","journal-title":"Mov. Disord."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1400447X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1400447X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T15:58:51Z","timestamp":1538409531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1400447X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":10,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0022510X1400447X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.07.004","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impulse control and repetitive behaviors in Parkinson's disease \u2014 Are there differences in the relation to dopamine agonist treatment?","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}